USA - NASDAQ:HYPR - US44916K1060 - Common Stock
The current stock price of HYPR is 1.07 USD. In the past month the price decreased by -38.86%. In the past year, price increased by 12.63%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.32 | 219.92B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.04 | 200.75B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.91 | 148.20B | ||
| SYK | STRYKER CORP | 27.03 | 136.11B | ||
| IDXX | IDEXX LABORATORIES INC | 56.18 | 56.68B | ||
| BDX | BECTON DICKINSON AND CO | 12.33 | 50.97B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.45 | 48.96B | ||
| RMD | RESMED INC | 25.4 | 36.70B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.92 | 33.35B | ||
| PODD | INSULET CORP | 69.98 | 22.51B | ||
| DXCM | DEXCOM INC | 29.57 | 21.57B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.94 | 17.53B |
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. The company is headquartered in Guilford, Connecticut and currently employs 111 full-time employees. The company went IPO on 2021-01-27. The firm is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.
HYPERFINE INC
351 New Whitfield Street
Guilford CONNECTICUT US
Employees: 111
Phone: 18667966767
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. The company is headquartered in Guilford, Connecticut and currently employs 111 full-time employees. The company went IPO on 2021-01-27. The firm is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.
The current stock price of HYPR is 1.07 USD. The price increased by 1.9% in the last trading session.
HYPR does not pay a dividend.
HYPR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
HYPR stock is listed on the Nasdaq exchange.
The Revenue of HYPERFINE INC (HYPR) is expected to grow by 5.2% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ChartMill assigns a technical rating of 1 / 10 to HYPR. When comparing the yearly performance of all stocks, HYPR turns out to be only a medium performer in the overall market: it outperformed 54.08% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to HYPR. While HYPR seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months HYPR reported a non-GAAP Earnings per Share(EPS) of -0.54. The EPS increased by 6.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -87.01% | ||
| ROE | -112.05% | ||
| Debt/Equity | 0 |
8 analysts have analysed HYPR and the average price target is 1.73 USD. This implies a price increase of 62.06% is expected in the next year compared to the current price of 1.07.
For the next year, analysts expect an EPS growth of 22.59% and a revenue growth 5.2% for HYPR